ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meningococcal Group A and C Conjugate Vaccine Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-19A17700
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Meningococcal Group A and C Conjugate Vaccine Market Research Report 2024
BUY CHAPTERS

Global Meningococcal Group A and C Conjugate Vaccine Market Research Report 2024

Code: QYRE-Auto-19A17700
Report
July 2024
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Vendors
Sanofi Pasteur
GSK
Pfizer Inc
Chongqing Zhifei Biological Products

Meningococcal Group A and C Conjugate Vaccine Market

The global Meningococcal Group A and C Conjugate Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Meningococcal Group A and C Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Meningococcal Group A and C Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Meningococcal Group A and C Conjugate Vaccine include Sanofi Pasteur, GSK, Pfizer, Chongqing Zhifei Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meningococcal Group A and C Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Group A and C Conjugate Vaccine.
The Meningococcal Group A and C Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Meningococcal Group A and C Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Group A and C Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Meningococcal Group A and C Conjugate Vaccine Market Report

Report Metric Details
Report Name Meningococcal Group A and C Conjugate Vaccine Market
Segment by Type
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, GSK, Pfizer, Chongqing Zhifei Biological Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meningococcal Group A and C Conjugate Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meningococcal Group A and C Conjugate Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Meningococcal Group A and C Conjugate Vaccine Market report?

Ans: The main players in the Meningococcal Group A and C Conjugate Vaccine Market are Sanofi Pasteur, GSK, Pfizer, Chongqing Zhifei Biological Products

What are the Application segmentation covered in the Meningococcal Group A and C Conjugate Vaccine Market report?

Ans: The Applications covered in the Meningococcal Group A and C Conjugate Vaccine Market report are Adults, Children

What are the Type segmentation covered in the Meningococcal Group A and C Conjugate Vaccine Market report?

Ans: The Types covered in the Meningococcal Group A and C Conjugate Vaccine Market report are Prefilled, Non-prefilled

Recommended Reports

Conjugate Vaccines

Bacterial Vaccines

Vaccine Market Trends

1 Meningococcal Group A and C Conjugate Vaccine Market Overview
1.1 Product Definition
1.2 Meningococcal Group A and C Conjugate Vaccine by Type
1.2.1 Global Meningococcal Group A and C Conjugate Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Prefilled
1.2.3 Non-prefilled
1.3 Meningococcal Group A and C Conjugate Vaccine by Application
1.3.1 Global Meningococcal Group A and C Conjugate Vaccine Market Value by Application (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Meningococcal Group A and C Conjugate Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Group A and C Conjugate Vaccine Revenue 2019-2030
1.4.2 Global Meningococcal Group A and C Conjugate Vaccine Sales 2019-2030
1.4.3 Global Meningococcal Group A and C Conjugate Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Meningococcal Group A and C Conjugate Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Meningococcal Group A and C Conjugate Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Meningococcal Group A and C Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meningococcal Group A and C Conjugate Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meningococcal Group A and C Conjugate Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Meningococcal Group A and C Conjugate Vaccine, Date of Enter into This Industry
2.8 Global Meningococcal Group A and C Conjugate Vaccine Market Competitive Situation and Trends
2.8.1 Global Meningococcal Group A and C Conjugate Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meningococcal Group A and C Conjugate Vaccine Players Market Share by Revenue
2.8.3 Global Meningococcal Group A and C Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meningococcal Group A and C Conjugate Vaccine Market Scenario by Region
3.1 Global Meningococcal Group A and C Conjugate Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Meningococcal Group A and C Conjugate Vaccine Sales by Region: 2019-2030
3.2.1 Global Meningococcal Group A and C Conjugate Vaccine Sales by Region: 2019-2024
3.2.2 Global Meningococcal Group A and C Conjugate Vaccine Sales by Region: 2025-2030
3.3 Global Meningococcal Group A and C Conjugate Vaccine Revenue by Region: 2019-2030
3.3.1 Global Meningococcal Group A and C Conjugate Vaccine Revenue by Region: 2019-2024
3.3.2 Global Meningococcal Group A and C Conjugate Vaccine Revenue by Region: 2025-2030
3.4 North America Meningococcal Group A and C Conjugate Vaccine Market Facts & Figures by Country
3.4.1 North America Meningococcal Group A and C Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Meningococcal Group A and C Conjugate Vaccine Sales by Country (2019-2030)
3.4.3 North America Meningococcal Group A and C Conjugate Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Meningococcal Group A and C Conjugate Vaccine Market Facts & Figures by Country
3.5.1 Europe Meningococcal Group A and C Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Meningococcal Group A and C Conjugate Vaccine Sales by Country (2019-2030)
3.5.3 Europe Meningococcal Group A and C Conjugate Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meningococcal Group A and C Conjugate Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Meningococcal Group A and C Conjugate Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Meningococcal Group A and C Conjugate Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Meningococcal Group A and C Conjugate Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Meningococcal Group A and C Conjugate Vaccine Market Facts & Figures by Country
3.7.1 Latin America Meningococcal Group A and C Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Meningococcal Group A and C Conjugate Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Meningococcal Group A and C Conjugate Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meningococcal Group A and C Conjugate Vaccine Sales by Type (2019-2030)
4.1.1 Global Meningococcal Group A and C Conjugate Vaccine Sales by Type (2019-2024)
4.1.2 Global Meningococcal Group A and C Conjugate Vaccine Sales by Type (2025-2030)
4.1.3 Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Meningococcal Group A and C Conjugate Vaccine Revenue by Type (2019-2030)
4.2.1 Global Meningococcal Group A and C Conjugate Vaccine Revenue by Type (2019-2024)
4.2.2 Global Meningococcal Group A and C Conjugate Vaccine Revenue by Type (2025-2030)
4.2.3 Global Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Meningococcal Group A and C Conjugate Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Meningococcal Group A and C Conjugate Vaccine Sales by Application (2019-2030)
5.1.1 Global Meningococcal Group A and C Conjugate Vaccine Sales by Application (2019-2024)
5.1.2 Global Meningococcal Group A and C Conjugate Vaccine Sales by Application (2025-2030)
5.1.3 Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Meningococcal Group A and C Conjugate Vaccine Revenue by Application (2019-2030)
5.2.1 Global Meningococcal Group A and C Conjugate Vaccine Revenue by Application (2019-2024)
5.2.2 Global Meningococcal Group A and C Conjugate Vaccine Revenue by Application (2025-2030)
5.2.3 Global Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Meningococcal Group A and C Conjugate Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Meningococcal Group A and C Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Meningococcal Group A and C Conjugate Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Meningococcal Group A and C Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Meningococcal Group A and C Conjugate Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Meningococcal Group A and C Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Meningococcal Group A and C Conjugate Vaccine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Chongqing Zhifei Biological Products
6.4.1 Chongqing Zhifei Biological Products Company Information
6.4.2 Chongqing Zhifei Biological Products Description and Business Overview
6.4.3 Chongqing Zhifei Biological Products Meningococcal Group A and C Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chongqing Zhifei Biological Products Meningococcal Group A and C Conjugate Vaccine Product Portfolio
6.4.5 Chongqing Zhifei Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meningococcal Group A and C Conjugate Vaccine Industry Chain Analysis
7.2 Meningococcal Group A and C Conjugate Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meningococcal Group A and C Conjugate Vaccine Production Mode & Process
7.4 Meningococcal Group A and C Conjugate Vaccine Sales and Marketing
7.4.1 Meningococcal Group A and C Conjugate Vaccine Sales Channels
7.4.2 Meningococcal Group A and C Conjugate Vaccine Distributors
7.5 Meningococcal Group A and C Conjugate Vaccine Customers
8 Meningococcal Group A and C Conjugate Vaccine Market Dynamics
8.1 Meningococcal Group A and C Conjugate Vaccine Industry Trends
8.2 Meningococcal Group A and C Conjugate Vaccine Market Drivers
8.3 Meningococcal Group A and C Conjugate Vaccine Market Challenges
8.4 Meningococcal Group A and C Conjugate Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Vendors
Sanofi Pasteur
GSK
Pfizer Inc
Chongqing Zhifei Biological Products
List of Tables
 Table 1. Global Meningococcal Group A and C Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Meningococcal Group A and C Conjugate Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Meningococcal Group A and C Conjugate Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Meningococcal Group A and C Conjugate Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Meningococcal Group A and C Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Meningococcal Group A and C Conjugate Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Meningococcal Group A and C Conjugate Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Meningococcal Group A and C Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Meningococcal Group A and C Conjugate Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Meningococcal Group A and C Conjugate Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Meningococcal Group A and C Conjugate Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meningococcal Group A and C Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Group A and C Conjugate Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meningococcal Group A and C Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Meningococcal Group A and C Conjugate Vaccine Sales by Region (2019-2024) & (K Units)
 Table 18. Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Meningococcal Group A and C Conjugate Vaccine Sales by Region (2025-2030) & (K Units)
 Table 20. Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Meningococcal Group A and C Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Meningococcal Group A and C Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Meningococcal Group A and C Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Meningococcal Group A and C Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
 Table 27. North America Meningococcal Group A and C Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
 Table 28. North America Meningococcal Group A and C Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Meningococcal Group A and C Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Meningococcal Group A and C Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Meningococcal Group A and C Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Meningococcal Group A and C Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Meningococcal Group A and C Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Meningococcal Group A and C Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Meningococcal Group A and C Conjugate Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Meningococcal Group A and C Conjugate Vaccine Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Meningococcal Group A and C Conjugate Vaccine Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Meningococcal Group A and C Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Meningococcal Group A and C Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Meningococcal Group A and C Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Meningococcal Group A and C Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Meningococcal Group A and C Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Meningococcal Group A and C Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Meningococcal Group A and C Conjugate Vaccine Sales (K Units) by Type (2019-2024)
 Table 51. Global Meningococcal Group A and C Conjugate Vaccine Sales (K Units) by Type (2025-2030)
 Table 52. Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Meningococcal Group A and C Conjugate Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Meningococcal Group A and C Conjugate Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Meningococcal Group A and C Conjugate Vaccine Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Meningococcal Group A and C Conjugate Vaccine Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Meningococcal Group A and C Conjugate Vaccine Sales (K Units) by Application (2019-2024)
 Table 61. Global Meningococcal Group A and C Conjugate Vaccine Sales (K Units) by Application (2025-2030)
 Table 62. Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Meningococcal Group A and C Conjugate Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Meningococcal Group A and C Conjugate Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Meningococcal Group A and C Conjugate Vaccine Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Meningococcal Group A and C Conjugate Vaccine Price (US$/Unit) by Application (2025-2030)
 Table 70. Sanofi Pasteur Company Information
 Table 71. Sanofi Pasteur Description and Business Overview
 Table 72. Sanofi Pasteur Meningococcal Group A and C Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Sanofi Pasteur Meningococcal Group A and C Conjugate Vaccine Product
 Table 74. Sanofi Pasteur Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Meningococcal Group A and C Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. GSK Meningococcal Group A and C Conjugate Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Meningococcal Group A and C Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Pfizer Meningococcal Group A and C Conjugate Vaccine Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Chongqing Zhifei Biological Products Company Information
 Table 86. Chongqing Zhifei Biological Products Description and Business Overview
 Table 87. Chongqing Zhifei Biological Products Meningococcal Group A and C Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Chongqing Zhifei Biological Products Meningococcal Group A and C Conjugate Vaccine Product
 Table 89. Chongqing Zhifei Biological Products Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Meningococcal Group A and C Conjugate Vaccine Distributors List
 Table 93. Meningococcal Group A and C Conjugate Vaccine Customers List
 Table 94. Meningococcal Group A and C Conjugate Vaccine Market Trends
 Table 95. Meningococcal Group A and C Conjugate Vaccine Market Drivers
 Table 96. Meningococcal Group A and C Conjugate Vaccine Market Challenges
 Table 97. Meningococcal Group A and C Conjugate Vaccine Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meningococcal Group A and C Conjugate Vaccine
 Figure 2. Global Meningococcal Group A and C Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Meningococcal Group A and C Conjugate Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Prefilled Product Picture
 Figure 5. Non-prefilled Product Picture
 Figure 6. Global Meningococcal Group A and C Conjugate Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Meningococcal Group A and C Conjugate Vaccine Market Share by Application: 2023 & 2030
 Figure 8. Adults
 Figure 9. Children
 Figure 10. Global Meningococcal Group A and C Conjugate Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Meningococcal Group A and C Conjugate Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Meningococcal Group A and C Conjugate Vaccine Sales (2019-2030) & (K Units)
 Figure 13. Global Meningococcal Group A and C Conjugate Vaccine Average Price (US$/Unit) & (2019-2030)
 Figure 14. Meningococcal Group A and C Conjugate Vaccine Report Years Considered
 Figure 15. Meningococcal Group A and C Conjugate Vaccine Sales Share by Manufacturers in 2023
 Figure 16. Global Meningococcal Group A and C Conjugate Vaccine Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Meningococcal Group A and C Conjugate Vaccine Players: Market Share by Revenue in Meningococcal Group A and C Conjugate Vaccine in 2023
 Figure 18. Meningococcal Group A and C Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Meningococcal Group A and C Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Country (2019-2030)
 Figure 21. North America Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Country (2019-2030)
 Figure 22. United States Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Country (2019-2030)
 Figure 25. Europe Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Region (2019-2030)
 Figure 33. China Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Meningococcal Group A and C Conjugate Vaccine Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Meningococcal Group A and C Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Meningococcal Group A and C Conjugate Vaccine by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Meningococcal Group A and C Conjugate Vaccine by Type (2019-2030)
 Figure 52. Global Meningococcal Group A and C Conjugate Vaccine Price (US$/Unit) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Meningococcal Group A and C Conjugate Vaccine by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Meningococcal Group A and C Conjugate Vaccine by Application (2019-2030)
 Figure 55. Global Meningococcal Group A and C Conjugate Vaccine Price (US$/Unit) by Application (2019-2030)
 Figure 56. Meningococcal Group A and C Conjugate Vaccine Value Chain
 Figure 57. Meningococcal Group A and C Conjugate Vaccine Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2024
Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningococcal Polysaccharide Vaccine Market Research Report 2025
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Research Report 2025
Meningococcal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 13 Valent Pneumococcal Conjugate Vaccine Market Research Report 2024
Global Meningitis Vaccine Market Research Report 2025
Global Prevent Meningitis Vaccine Market Research Report 2025
Global Meningococcal Infections Vaccine Market Insights Forecast to 2030
Meningococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Vaccine for Non infectious Meningitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 13 Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Research Report 2024
Global Meningococcal Infections Treatment Market Research Report 2024
Global Neisseria meningitidis Infections Drug Market Research Report 2024
Multivalent Pneumococcal Conjugate Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Streptococcus Group A Antibodies Market Research Report 2024
Global Adult Vaccines Market Research Report 2024
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024
Global Haemophilus Influenzae Type b Conjugate Vaccine Market Research Report 2025
Global Adult and Pediatric Vaccines Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions